REFERENCES
- FukuharaAMatsudaMNishizawaMSegawaKTanakaMKishimotoKMatsukiYMurakamiMIchisakaTMurakamiHWatanabeETakagiTAkiyoshiMOhtsuboTKiharaSYamashitaSMakishimaMFunahashiTYamanakaSHiramatsuRMatsuzawaYShimomuraI: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307: 426– 430, 2005.
- SommerGGartenAPetzoldSBeck-SickingerABlüherMStumvollMFasshauerM: Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci (Lond) 115: 13– 23, 2008.
- FukuharaAMatsudaMNishizawaMSegawaKTanakaMKishimotoKMatsukiYMurakamiMIchisakaTMurakamiHWatanabeETakagiTAkiyoshiMOhtsuboTKiharaSYamashitaSMakishimaMFunahashiTYamanakaSHiramatsuRMatsuzawaYShimomuraI: Retraction. Science 318: 565, 2007.
- RevolloJKörnerAMillsKSatohAWangTGartenADasguptaBSasakiYWolbergerCTownsendRMilbrandtJKiessWImaiS: Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 6: 363– 375, 2007.
- BoucherJMasriBDaviaudDGestaSGuignéCMazzucotelliACastan-LaurellITackIKnibiehlerBCarpénéCAudigierYSaulnier-BlacheJValetP: Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146: 1764– 1771, 2005.
- CarpénéCDrayCAttanéCValetPPortilloMChurrucaIMilagroFCastan-LaurellI: Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 63: 359– 373, 2007.
- HiguchiKMasakiTGotohKChibaSKatsuragiITanakaKKakumaTYoshimatsuH: Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 148: 2690– 2697, 2007.
- DrayCKnaufCDaviaudDWagetABoucherJBuléonMCaniPDAttanéCGuignéCCarpénéCBurcelinRCastan-LaurellIValetP: Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 8: 437– 445, 2008.
- ReevesPGNielsenFHFaheyGCJr: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939– 1951, 1993.
- MatthewsDHoskerJRudenskiANaylorBTreacherDTurnerR: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412– 419, 1985.
- LivakKSchmittgenT: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402– 408, 2001.
- BoydJContrerasIKernMTapscottEDownesDFrisellWDohmG: Effect of a high-fat-sucrose diet on in vivo insulin receptor kinase activation. Am J Physiol 259: E111– 116, 1990.
- KraegenEWClarckPWJenkinsABDaleyEAChisholmDJStorlienLH: Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40: 1397– 1403, 1991.
- Kasim-KarakasSVriendHAlmarioRChowLGoodmanM: Effects of dietary carbohydrates on glucose and lipid metabolism in golden Syrian hamsters. J Lab Clin Med 128: 208– 213, 1996.
- PagliassottiMPrachPKoppenhaferTPanD: Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats. Am J Physiol 271: R1319– R1326, 1996.
- YaspelkisBSinghMKrisanACollinsDKwongCBernardJCrainA: Chronic leptin treatment enhances insulin-stimulated glucose disposal in skeletal muscle of high-fat fed rodents. Life Sci 74: 1801– 1816, 2004.
- BarzilaiNBanerjeeSHawkinsMChenWRossettiL: Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest 101: 1353– 1361, 1998.
- DhahbiJMotePWingoJRowleyBCaoSWalfordRSpindlerS: Caloric restriction alters the feeding response of key metabolic enzyme genes. Mech Ageing Dev 122: 1033– 1048, 2001.
- PoirierHNiotIClémentLGuerre-MilloMBesnardP: Development of conjugated linoleic acid (CLA)-mediated lipoatrophic syndrome in the mouse. Biochimie 87: 73– 79, 2005.
- Tsuboyama-KasaokaNTakahashiMTanemuraKKimHTangeTOkuyamaHKasaiMIkemotoSEzakiO: Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49: 1534– 1542, 2000.
- RisérusUVessbyBArnerPZetheliusB: Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 47: 1016– 1019, 2004.
- HouseknechtKVanden HeuvelJMoya-CamarenaSPortocarreroCPeckLNickelKBeluryM: Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 244: 678– 682, 1998.
- HenriksenETeacheyMTaylorZJacobSPtockAKrämerKHasselwanderO: Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat. Am J Physiol Endocrinol Metab 285: E98– E105, 2003.
- KlötingNKlötingI: Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. Biochem Biophys Res Commun 332: 1070– 1072, 2005.
- MercaderJGranadosNCaimariAOliverPBonetMPalouA: Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models. Horm Metab Res 40: 467– 472, 2008.
- Pérez-EcharriNPérez-MatutePMarcos-GómezBMartínezJAMoreno-AliagaMJ: Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (high-fat fed) rats. Br J Nutr 101: 1059– 1067, 2009.
- SunGBishopJKhaliliSVasdevSGillVPaceDFitzpatrickDRandellEXieYGZhangH: Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am J Clin Nutr 85: 399– 404, 2007.
- SheaJRandellEVasdevSWangPPRoebothanBSunG: Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normal-weight, overweight, and obese men. Am J Clin Nutr 86: 1310– 1315, 2007.
- HaiderDMittermayerFSchallerGArtwohlMBaumgartner-ParzerSPragerGRodenMWolztM: Free fatty acids normalize a rosiglitazone-induced visfatin release. Am J Physiol Endocrinol Metab 291: E885– E890, 2006.
- SwarbrickMStanhopeKAustrheim-SmithIVan LoanMAliMWolfeBHavelP: Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 51: 1901– 1911, 2008.
- SheuWChangTLeeWOuHWuCTsengLLangHWuCWanCLeeI: Effect of weight loss on proinflammatory state of mononuclear cells in obese women. Obesity (Silver Spring) 16: 1033– 1038, 2008.
- de LuisDGonzalez SagradoMCondeRAllerRIzaolaORomeroE: Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients. Nutrition 24: 517– 521, 2008.
- KrzyzanowskaKMittermayerFKruglugerWKoppHSchernthanerG: Increase in visfatin after weight loss induced by gastroplastic surgery. Obesity (Silver Spring) 14: 1886– 1889, 2006.
- Botella-CarreteroJLuque-RamírezMAlvarez-BlascoFPeromingoRSan MillánJEscobar-MorrealeH: The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery. Obes Surg 18: 1000– 1006, 2008.
- García-FuentesEGarcía-AlmeidaJGarcía-ArnésJGarcía-SerranoSRivas-MarínJGallego-PeralesJRojo-MartínezGGarrido-SánchezLBermudez-SilvaFRodríguez de FonsecaFSoriguerF: Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obesity (Silver Spring) 15: 2391– 2395, 2007.
- KerstenS: Peroxisome proliferator activated receptors and obesity. Eur J Pharmacol 440: 223– 234, 2002.
- KhanSVanden HeuvelJ: Role of nuclear receptors in the regulation of gene expression by dietary fatty acids (review). J Nutr Biochem 14: 554– 567, 2003.
- FerréP: The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53 (suppl 1): S43– S50, 2004.
- GurnellM: Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies. Best Pract Res Clin Endocrinol Metab 19: 501– 523, 2005.
- ChoiKRyuOLeeKKimHSeoJKimSKimNChoiDBaikSChoiK: Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats. Biochem Biophys Res Commun 336: 747– 753, 2005.
- HammarstedtAPihlajamäkiJRotter SopasakisVGoggSJanssonPLaaksoMSmithU: Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab 91: 1181– 1184, 2006.
- MacLarenRCuiWCianfloneK: Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3-L1 pre-adipocytes and adipocytes. Diabetes Obes Metab 9: 490– 497, 2007.
- KangKLiuWAlbrightKParkYParizaM: Trans-10,cis-12 CLA inhibits differentiation of 3T3-L1 adipocytes and decreases PPAR gamma expression. Biochem Biophys Res Commun 303: 795– 799, 2003.
- TakahashiYKushiroMShinoharaKIdeT: Dietary conjugated linoleic acid reduces body fat mass and affects gene expression of proteins regulating energy metabolism in mice. Comp Biochem Physiol B Biochem Mol Biol 133: 395– 404, 2002.
- ZabalaAChurrucaIFernández-QuintelaARodríguezVMacarullaMMartínezJPortilloM: Trans-10,cis-12 conjugated linoleic acid inhibits lipoprotein lipase but increases the activity of lipogenic enzymes in adipose tissue from hamsters fed an atherogenic diet. Br J Nutr 95: 1112– 1119, 2006.
- KangKLiuWAlbrightKJParkYParizaMW: Trans-10,cis-12 CLA inhibits differentiation of 3T3-L1 adipocytes and decreases PPARc expression. Biochem Biophys Res Commun 303: 795– 799, 2003.
- CrujeirasAParraDGoyenecheaEMartínezJ: Sirtuin gene expression in human mononuclear cells is modulated by caloric restriction. Eur J Clin Invest 38: 672– 678, 2008.
- HaigisMGuarenteL: Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction. Genes Dev 20: 2913– 2921, 2006.
- JiangW: Sirtuins: novel targets for metabolic disease in drug development. Biochem Biophys Res Commun 373: 341– 344, 2008.
- Castan-LaurellIBoucherJDrayCDaviaudDGuignéCValetP: Apelin, a novel adipokine over-produced in obesity: friend or foe? Mol Cell Endocrinol 245: 7– 9, 2005.
- OdaNImamuraSFujitaTUchidaYInagakiKKakizawaHHayakawaNSuzukiATakedaJHorikawaYItohM: The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 57: 268– 273, 2008.